SAREPTA THERAPEUTICS ANNOUNCES SUBMISSION OF CLINICAL TRIAL APPLICATION FOR SRP-1005, ITS INVESTIGATIONAL TREATMENT FOR HUNTINGTON’S DISEASE

Reuters · 4d ago

Please log in to view news